Table of Contents
ISRN Gastroenterology
Volume 2013 (2013), Article ID 205417, 5 pages
http://dx.doi.org/10.1155/2013/205417
Clinical Study

Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice

Department of Internal Medicine and Gastroenterology, Zaans Medical Centre, P.O. BOX 210, 1500 EE Zaandam, The Netherlands

Received 28 February 2013; Accepted 27 March 2013

Academic Editors: A. K. Rishi and A. Weimann

Copyright © 2013 R. J. L. F. Loffeld and P. E. P. Dekkers. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” Ca-A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Google Scholar · View at Scopus
  2. B. A. Grotenhuis, P. van Hagen, B. P. L. Wijnhoven, M. C. W. Spaander, H. W. Tilanus, and J. J. B. van Lanschot, “Delay in diagnostic workup and treatment of esophageal cancer,” Journal of Gastrointestinal Surgery, vol. 14, no. 3, pp. 476–483, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Brown, S. S. Devesa, and W. H. Chow, “Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age,” Journal of the National Cancer Institute, vol. 100, no. 16, pp. 1184–1187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. H. Yoon, M. Khan, Q. Shi et al., “The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a Mayo cohort of 796 patients with extended follow-up after surgical resection,” Mayo Clinic Proceedings, vol. 85, no. 12, pp. 1080–1089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. P. Campbell and V. M. Villaflor, “Neoadjuvant treatment of esophageal cancer,” World Journal of Gastroenterology, vol. 16, no. 30, pp. 3793–3803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. F. Hulscher, J. W. Van Sandick, A. G. E. M. De Boer et al., “Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus,” New England Journal of Medicine, vol. 347, no. 21, pp. 1662–1669, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. L. Jin, H. Zhu, T. S. Ling, H. J. Zhang, and R. H. Shi, “Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis,” World Journal of Gastroenterology, vol. 15, no. 47, pp. 5983–5991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. P. Dawsey, S. Tonui, R. K. Parker et al., “Esophageal cancer in young people: a case series of 109 cases and review of the literature,” PLoS ONE, vol. 5, no. 11, Article ID e14080, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Kuwahara, M. Yamamori, K. Kadoyama et al., “Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma,” Journal of Experimental & Clinical Cancer Research, vol. 30, article 94, 2011. View at Google Scholar